Transcarent raises $200M in Series C funding

California-based healthcare company, Transcarent, raised $200 million in their Series C fund round by Kinnevik and Human Capital.

California-based healthcare company, Transcarent, raised $200 million in their Series C fund round by Kinnevik and Human Capital. Other participants were Ally Bridge Group, Northwell Health, Intermountain Healthcare, and Rush University Medical Center. Existing investors too participated in the round, namely, General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund, Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures. 

Currently, the company is under the leadership of Glen Tullman. The series C round of funding gives Transcarent a valuation of $1.6 billion, making it another digital health venture to enter the unicorn club.

Transcarent was made for employees of self-insured employers and their families. The platform provides an ecosystem that helps fulfil all medical needs of the patient. This ranges from health evaluation to speciality care like surgery and home care. Patients can get access to live and direct guidance to healthcare professionals around the clock. 

Transcarent offers what no other company offers - a fully at-risk model which pays providers up-front for care and partners with employers without any up-front or per-employee-per-month (PEPM) fees. This model makes it possible for members to receive no bill. In October 2020, the company had received $40 million in their Series A round led by 7wireVentures and General Catalyst. The same year, Transcarent acquired BridgeHealth. Last year they had raised $58 million in their Series B round.

Tags : #Transcarent #Kinnevik #HumanCapital #GeneralCatalyst #7wireVentures #AltaPartners #MerckGlobalHealthInnovationFund #JoveEquityPartners #ThresholdVentures #GreatPointVentures #funding #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024
Empowering Patients: The Role of Advocacy in Indian HealthcareMarch 26, 2024
A New Dawn in Heart Surgery: Mitral Valve Repair for 15-Year-Old PatientMarch 26, 2024